Lina Leiss

1.2k total citations
20 papers, 810 citations indexed

About

Lina Leiss is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Lina Leiss has authored 20 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Lina Leiss's work include Glioma Diagnosis and Treatment (9 papers), Cancer Cells and Metastasis (5 papers) and Immune cells in cancer (4 papers). Lina Leiss is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Cancer Cells and Metastasis (5 papers) and Immune cells in cancer (4 papers). Lina Leiss collaborates with scholars based in Norway, Sweden and China. Lina Leiss's co-authors include Per Øyvind Enger, Linda Sleire, Hilde Elise Førde, Inger Anne Netland, Bente Sandvei Skeie, Jian Wang, Hrvoje Miletić, Xingang Li, Frode Selheim and Ernest Dodoo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Oncogene.

In The Last Decade

Lina Leiss

20 papers receiving 804 citations

Peers

Lina Leiss
Linda Sleire Norway
Constantinos Alifieris Greece
Roberto Würth Italy
Kristen L. Jones United States
Sivan Izraely Israel
Andrea Shergalis United States
Arabel Vollmann‐Zwerenz Germany
Kruttika Bhat United States
Patrick T. Grogan United States
Linda Sleire Norway
Lina Leiss
Citations per year, relative to Lina Leiss Lina Leiss (= 1×) peers Linda Sleire

Countries citing papers authored by Lina Leiss

Since Specialization
Citations

This map shows the geographic impact of Lina Leiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Leiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Leiss more than expected).

Fields of papers citing papers by Lina Leiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Leiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Leiss. The network helps show where Lina Leiss may publish in the future.

Co-authorship network of co-authors of Lina Leiss

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Leiss. A scholar is included among the top collaborators of Lina Leiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Leiss. Lina Leiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avenel, Christophe, et al.. (2023). Visualization and quality control tools for large-scale multiplex tissue analysis in TissUUmaps3. SHILAP Revista de lepidopterología. 3. e6–e6. 3 indexed citations
2.
Solorzano, Leslie, Lina Leiss, Thomas Olsson Bontell, et al.. (2021). Machine learning for cell classification and neighborhood analysis in glioma tissue. Cytometry Part A. 99(12). 1176–1186. 9 indexed citations
3.
Su, Yanhong, Andri Papakonstantinou, Nicholas P. Tobin, et al.. (2021). CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma. Cancers. 13(5). 1175–1175. 1 indexed citations
4.
Mezheyeuski, Artur, Ulrika Segersten, Lina Leiss, et al.. (2020). Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome. Scientific Reports. 10(1). 281–281. 44 indexed citations
5.
Leiss, Lina, et al.. (2019). Double Immunohistochemistry and Digital Image Analysis. Methods in molecular biology. 1913. 3–11. 2 indexed citations
6.
7.
Leiss, Lina, Nicholas P. Tobin, Hrvoje Miletić, et al.. (2019). Astrocytes enhance glioblastoma growth. Glia. 68(2). 316–327. 56 indexed citations
8.
Zhang, Xing‐Mei, Sara Bolin, Anne‐Laure Joly, et al.. (2018). Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity. iScience. 9. 71–83. 38 indexed citations
9.
Leiss, Lina, et al.. (2017). Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses. Experimental Cell Research. 359(1). 257–265. 4 indexed citations
10.
Leiss, Lina, Anne M. Øyan, Tao Yan, et al.. (2017). Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. BMC Cancer. 17(1). 108–108. 9 indexed citations
11.
Leiss, Lina, Ning Yang, Cecilie Brekke Rygh, et al.. (2017). Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy. Oncotarget. 8(7). 12145–12157. 55 indexed citations
12.
Sleire, Linda, Hilde Elise Førde, Inger Anne Netland, et al.. (2017). Drug repurposing in cancer. Pharmacological Research. 124. 74–91. 247 indexed citations
13.
Netland, Inger Anne, Hilde Elise Førde, Linda Sleire, et al.. (2016). Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models. BMC Cancer. 16(1). 657–657. 24 indexed citations
14.
Netland, Inger Anne, Hilde Elise Førde, Linda Sleire, et al.. (2016). Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. Journal of Neuro-Oncology. 129(1). 57–66. 26 indexed citations
15.
Sleire, Linda, Bente Sandvei Skeie, Inger Anne Netland, et al.. (2015). Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc−, leading to glutathione depletion. Oncogene. 34(49). 5951–5959. 148 indexed citations
16.
Yang, Ning, Tao Yan, Kristina Xiao Liang, et al.. (2014). A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma. Journal of Translational Medicine. 12(1). 278–278. 43 indexed citations
17.
Yang, Ning, Bin Huang, Oleg Tsinkalovsky, et al.. (2014). A novel GFP nude rat model to investigate tumor-stroma interactions. Cancer Cell International. 14(1). 541–541. 4 indexed citations
18.
Navarro, Andrea Gras, Justyna Kmiecik, Lina Leiss, et al.. (2014). NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival. The Journal of Immunology. 193(12). 6192–6206. 42 indexed citations
19.
Eskilsson, Eskil, Krishna M. Talasila, Lina Leiss, et al.. (2014). AI-10 * DISTINCT EGFR SIGNALING IN GLIOBLASTOMA: WILD-TYPE EGFR PROMOTES INVASION WHILE EGFRvIII DRIVES PROTOTYPICAL SFK c-SRC ACTIVATION TO FOSTER ANGIOGENESIS. Neuro-Oncology. 16(suppl 5). v3–v3. 1 indexed citations
20.
Yan, Tao, Kai Ove Skaftnesmo, Lina Leiss, et al.. (2011). Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. BMC Cancer. 11(1). 524–524. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Sleire Breakdown of academic impact, for papers by Constantinos Alifieris Breakdown of academic impact, for papers by Roberto Würth Breakdown of academic impact, for papers by Kristen L. Jones Breakdown of academic impact, for papers by Sivan Izraely Breakdown of academic impact, for papers by Andrea Shergalis Breakdown of academic impact, for papers by Arabel Vollmann‐Zwerenz Breakdown of academic impact, for papers by Kruttika Bhat Breakdown of academic impact, for papers by Patrick T. Grogan
Rankless by CCL
2026